Ge Ruowen
Corporate Officer/Principal chez National University of Singapore
Profil
Ge Ruowen is the founder of ProTherapeutics Pte Ltd, which was founded in 2005.
She held the title of Scientist Officer.
Currently, she is a Principal at the National University of Singapore.
Dr. Ruowen received a doctorate degree from the University of Pennsylvania in 1992.
Postes actifs de Ge Ruowen
| Sociétés | Poste | Début |
|---|---|---|
| National University of Singapore | Corporate Officer/Principal | 26/02/2010 |
Anciens postes connus de Ge Ruowen
| Sociétés | Poste | Fin |
|---|---|---|
ProTherapeutics Pte Ltd.
 ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Fondateur | - |
Formation de Ge Ruowen
| University of Pennsylvania | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
ProTherapeutics Pte Ltd.
ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Health Technology |
